Advanced search
Start date
Betweenand


The NLRP3 inflammasome and its role in acute myeloid leukemia onset and development

Full text
Author(s):
de Macedo, Brunno Gilberto Santos ; de Melo, Manuela Albuquerque ; Pereira-Martins, Diego Antonio ; Machado-Neto, Joao Agostinho ; Traina, Fabiola
Total Authors: 5
Document type: Journal article
Source: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER; v. 1880, n. 4, p. 10-pg., 2025-09-01.
Abstract

The tumor microenvironment plays an important role in cancer onset and progression. Its significance has been increasingly addressed in myeloid neoplasms. Such a shift marks a departure from the usual tumor-centered approach to a more comprehensive and integrated understanding of the interplay between myeloid tumors and their surroundings. On this note, we aimed to summarize, in this review, an up-to-date take on how a pro-inflammatory milieu influences clonal selection of genetically altered hematopoietic stem cells towards myeloid malignancies at the expense of their healthy counterpart; the role of NLRP3 inflammasome, a major component of the innate immunity and source of interleukin-1 beta, over acute myeloid leukemia development and performance; and, alongside post-translational modifications, how autophagy represents a major NLRP3 inflammasome regulator. (AU)

FAPESP's process: 23/09514-9 - Investigation of mitochondrial metabolism in the biology of myelodysplastic syndrome
Grantee:Manuela Albuquerque de Melo
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 22/03871-1 - Functional and molecular investigation of the correlation between autophagy, NLRP3-inflammasome and hemostasis on acute myeloid leukemia
Grantee:Brunno Gilberto Santos de Macedo
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 13/08135-2 - CTC - Center for Cell-Based Therapy
Grantee:Dimas Tadeu Covas
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC
FAPESP's process: 14/50947-7 - INCT 2014: in Stem Cell and Cell Therapy
Grantee:Dimas Tadeu Covas
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 21/11112-0 - Assessment of autophagy as a therapeutic efficiency limiting mechanism of FLT3 pharmacological inhibitors on acute myeloid leukemia
Grantee:Manuela Albuquerque de Melo
Support Opportunities: Scholarships in Brazil - Master